Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 104

Results For "design"

1666 News Found

Clariant launches Plantasens Pro LM
News | March 10, 2023

Clariant launches Plantasens Pro LM

Plantasens Pro LM is 100% natural, readily biodegradable, COSMOS and Natrue certified


Lonza upgrades powder characterization capabilities at Tampa
News | March 09, 2023

Lonza upgrades powder characterization capabilities at Tampa

The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation


93% companies lack the culture and organizational structure to unlock digital growth: Infosys
Digitisation | March 08, 2023

93% companies lack the culture and organizational structure to unlock digital growth: Infosys

Digital success is contingent on the way a company organizes itself around technology


Venus Remedies joins India AMR Innovation Hub
News | March 07, 2023

Venus Remedies joins India AMR Innovation Hub

lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid


Jan Aushadhi Train flagged off by Mandaviya and Vaishnaw in New Delhi
News | March 04, 2023

Jan Aushadhi Train flagged off by Mandaviya and Vaishnaw in New Delhi

Jan Aushadhi highlights achievements of women of the country at 34 locations by felicitating all women stakeholders under the scheme


Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging
News | March 03, 2023

Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging

Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event


ENHERTU approved in China for patients with HER2 positive metastatic breast cancer treated withantiHER2-based regimens
News | February 28, 2023

ENHERTU approved in China for patients with HER2 positive metastatic breast cancer treated withantiHER2-based regimens

First approval for Daiichi Sankyo and AstraZeneca’s ENHERTU in China


SERDA therapeutics submits IND for wound debridement agent
Drug Approval | February 24, 2023

SERDA therapeutics submits IND for wound debridement agent

Clinical studies are expected to start in Q2 2023.


Moderna and Merck announce investigational personalized cancer vaccine mRNA-4157/V940
Drug Approval | February 23, 2023

Moderna and Merck announce investigational personalized cancer vaccine mRNA-4157/V940

Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial